Health

Will a **therapeutic vaccine** for a chronic viral infection (e.g., HIV, HSV) successfully complete Phase 2 human trials by 2026?

Forecasting a major milestone in infectious disease treatment using next-generation vaccine technology.

Yes 60%Maybe 0%No 40%

5 total votes

Comments